NXTC FY 2021 Earnings — NextCure, Inc. Revenue & Financial Results | Market Cap Arena

NXTCNextCure, Inc.

$36M

FY 2021 Earnings

Healthcare Biotechnology

Income Statement

Revenue

$0-100.0% YoY

Gross Profit

$0

Operating Income

-$71M

Net Income

-$69M

EPS (Diluted)

$-30.15

Cash Flow

Operating Cash Flow

-$57M

Free Cash Flow

-$60M

Stock-Based Comp.

$10M

Balance Sheet

Total Assets

$242M

Total Liabilities

$9M

Stockholders' Equity

$233M

Cash & Equivalents

$12M

Year-over-Year Comparison

Metric	Current	Year Ago	Change
Revenue	$0	$22M	-100.0%
Gross Profit	$0	-$24M	+100.0%
Operating Income	-$71M	-$41M	-71.7%
Net Income	-$69M	-$37M	-89.6%